title: Abortion of the UVEXATE study: are we unable to evaluate cheap and well-tolerated treatments?
authors.affiliation: Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris 13, Sorbonne Paris Cité, Bobigny, France.
authors.forename: François
authors.initials: F
authors.lastname: Rodrigues
authors.affiliation: Unité de Recherche Clinique, Hôpital Fernand Widal, AP-HP; Université Paris 7, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Vicaut
authors.affiliation: Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris 13, Sorbonne Paris Cité, Bobigny, France. sebastien.abad@avc.aphp.fr.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Abad
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014605:Uveitis / Q000188:drug therapy*; D028761:Withholding Treatment
chemical_list: D007166:Immunosuppressive Agents; D008727:Methotrexate